Associations of urinary 8-iso-prostaglandin F2α levels with all-cause dementia, Alzheimer's disease, and vascular dementia incidence: results from a prospective cohort study

Introduction Prospective studies on a potential association of 8-iso-prostaglandin F2α (8-iso-PGF2α) levels, a biomarker of lipid peroxidation, with dementia are limited. Methods Multivariate Cox regression models were used to assess potential associations of urinary 8-iso-PGF2α levels with all-caus...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Trares, Kira (VerfasserIn) , Gào, Xīn (VerfasserIn) , Perna, Laura (VerfasserIn) , Rujescu, Dan (VerfasserIn) , Stocker, Hannah (VerfasserIn) , Möllers, Tobias (VerfasserIn) , Beyreuther, Konrad (VerfasserIn) , Brenner, Hermann (VerfasserIn) , Schöttker, Ben (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 12 April 2020
In: Alzheimer's and dementia
Year: 2020, Jahrgang: 16, Heft: 5, Pages: 804-813
ISSN:1552-5279
DOI:https://doi.org/10.1002/alz.12081
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/https://doi.org/10.1002/alz.12081
Verlag, lizenzpflichtig, Volltext: https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.12081
Volltext
Verfasserangaben:Kira Trares, Xīn Gào, Laura Perna, Dan Rujescu, Hannah Stocker, Tobias Möllers, Konrad Beyreuther, Hermann Brenner, Ben Schöttker

MARC

LEADER 00000caa a2200000 c 4500
001 1738318966
003 DE-627
005 20230428161340.0
007 cr uuu---uuuuu
008 201110s2020 xx |||||o 00| ||eng c
024 7 |a 10.1002/alz.12081  |2 doi 
035 |a (DE-627)1738318966 
035 |a (DE-599)KXP1738318966 
035 |a (OCoLC)1341375289 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Trares, Kira  |d 1994-  |e VerfasserIn  |0 (DE-588)1221159763  |0 (DE-627)1738319326  |4 aut 
245 1 0 |a Associations of urinary 8-iso-prostaglandin F2α levels with all-cause dementia, Alzheimer's disease, and vascular dementia incidence  |b results from a prospective cohort study  |c Kira Trares, Xīn Gào, Laura Perna, Dan Rujescu, Hannah Stocker, Tobias Möllers, Konrad Beyreuther, Hermann Brenner, Ben Schöttker 
246 3 3 |a Associations of urinary 8-iso-prostaglandin F2 alpha levels with all-cause dementia, Alzheimer's disease, and vascular dementia incidence$dresults from a prospective cohort study 
264 1 |c 12 April 2020 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Titel ist "2α" tiefgestellt 
500 |a Gesehen am 10.11.2020 
520 |a Introduction Prospective studies on a potential association of 8-iso-prostaglandin F2α (8-iso-PGF2α) levels, a biomarker of lipid peroxidation, with dementia are limited. Methods Multivariate Cox regression models were used to assess potential associations of urinary 8-iso-PGF2α levels with all-cause, Alzheimer's disease (AD), and vascular dementia (VD) incidence in 5853 older adults from a German, population-based cohort. Results Over 14 years of follow-up, 365 all-cause dementia cases including 127 VD and 109 AD cases were diagnosed. Participants in the top compared to the bottom 8-iso-PGF2α tertile had a 45% increased risk of all-cause dementia incidence (hazard ratio [95% confidence interval]: 1.45 [1.12 to 1.88]). Interaction with the apolipoprotein E (APOE) ԑ4/ԑ4 genotype was detected (P = .02). Furthermore, continuously modeled, logarithmized 8-iso-PGF2α levels were statistically significantly associated with all-cause dementia and AD incidence. Discussion Oxidative stress may be involved in the pathogenesis of dementia. Individuals with increased 8-iso-PGF2α levels and the APOE ԑ4/ԑ4 genotype showed a considerably increased dementia risk. 
650 4 |a 8-iso-prostaglandin F2α 
650 4 |a Alzheimer's disease 
650 4 |a cohort study 
650 4 |a dementia 
650 4 |a oxidative stress 
650 4 |a vascular dementia 
700 1 |a Gào, Xīn  |e VerfasserIn  |4 aut 
700 1 |a Perna, Laura  |e VerfasserIn  |4 aut 
700 1 |a Rujescu, Dan  |e VerfasserIn  |4 aut 
700 1 |a Stocker, Hannah  |d 1990-  |e VerfasserIn  |0 (DE-588)116628199X  |0 (DE-627)1030292507  |0 (DE-576)510710271  |4 aut 
700 1 |a Möllers, Tobias  |d 1990-  |e VerfasserIn  |0 (DE-588)1165087197  |0 (DE-627)1029274975  |0 (DE-576)510241336  |4 aut 
700 1 |a Beyreuther, Konrad  |d 1941-  |e VerfasserIn  |0 (DE-588)133652580  |0 (DE-627)550295852  |0 (DE-576)299999424  |4 aut 
700 1 |a Brenner, Hermann  |e VerfasserIn  |0 (DE-588)1020516445  |0 (DE-627)691247005  |0 (DE-576)360642136  |4 aut 
700 1 |a Schöttker, Ben  |e VerfasserIn  |0 (DE-588)138862443  |0 (DE-627)703132423  |0 (DE-576)309375657  |4 aut 
773 0 8 |i Enthalten in  |t Alzheimer's and dementia  |d Hoboken, NJ : Wiley, 2005  |g 16(2020), 5, Seite 804-813  |h Online-Ressource  |w (DE-627)499546059  |w (DE-600)2201940-6  |w (DE-576)255666330  |x 1552-5279  |7 nnas  |a Associations of urinary 8-iso-prostaglandin F2α levels with all-cause dementia, Alzheimer's disease, and vascular dementia incidence results from a prospective cohort study 
773 1 8 |g volume:16  |g year:2020  |g number:5  |g pages:804-813  |g extent:10  |a Associations of urinary 8-iso-prostaglandin F2α levels with all-cause dementia, Alzheimer's disease, and vascular dementia incidence results from a prospective cohort study 
856 4 0 |u https://doi.org/https://doi.org/10.1002/alz.12081  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.12081  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201110 
993 |a Article 
994 |a 2020 
998 |g 138862443  |a Schöttker, Ben  |m 138862443:Schöttker, Ben  |d 850000  |d 851600  |d 50000  |e 850000PS138862443  |e 851600PS138862443  |e 50000PS138862443  |k 0/850000/  |k 1/850000/851600/  |k 0/50000/  |p 9  |y j 
998 |g 1020516445  |a Brenner, Hermann  |m 1020516445:Brenner, Hermann  |d 850000  |d 851600  |d 50000  |e 850000PB1020516445  |e 851600PB1020516445  |e 50000PB1020516445  |k 0/850000/  |k 1/850000/851600/  |k 0/50000/  |p 8 
998 |g 133652580  |a Beyreuther, Konrad  |m 133652580:Beyreuther, Konrad  |d 850000  |d 851600  |d 50000  |e 850000PB133652580  |e 851600PB133652580  |e 50000PB133652580  |k 0/850000/  |k 1/850000/851600/  |k 0/50000/  |p 7 
998 |g 1165087197  |a Möllers, Tobias  |m 1165087197:Möllers, Tobias  |d 850000  |d 851600  |d 50000  |e 850000PM1165087197  |e 851600PM1165087197  |e 50000PM1165087197  |k 0/850000/  |k 1/850000/851600/  |k 0/50000/  |p 6 
998 |g 116628199X  |a Stocker, Hannah  |m 116628199X:Stocker, Hannah  |p 5 
998 |g 1221159763  |a Trares, Kira  |m 1221159763:Trares, Kira  |d 50000  |e 50000PT1221159763  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1738318966  |e 3796368190 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"note":["Gesehen am 19.03.2024"],"pubHistory":["1.2005 -"],"recId":"499546059","disp":"Associations of urinary 8-iso-prostaglandin F2α levels with all-cause dementia, Alzheimer's disease, and vascular dementia incidence results from a prospective cohort studyAlzheimer's and dementia","part":{"text":"16(2020), 5, Seite 804-813","pages":"804-813","volume":"16","issue":"5","extent":"10","year":"2020"},"title":[{"title_sort":"Alzheimer's and dementia","subtitle":"the journal of the Alzheimer's Association","title":"Alzheimer's and dementia"}],"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["2201940-6"],"issn":["1552-5279"],"eki":["499546059"],"doi":["10.1002/(ISSN)1552-5279"]},"language":["eng"],"origin":[{"publisherPlace":"Hoboken, NJ ; Amsterdam","dateIssuedDisp":"2005-","dateIssuedKey":"2005","publisher":"Wiley ; Elsevier"}]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"id":{"eki":["1738318966"],"doi":["10.1002/alz.12081"]},"person":[{"role":"aut","given":"Kira","family":"Trares","display":"Trares, Kira"},{"given":"Xīn","display":"Gào, Xīn","family":"Gào","role":"aut"},{"family":"Perna","display":"Perna, Laura","given":"Laura","role":"aut"},{"role":"aut","display":"Rujescu, Dan","family":"Rujescu","given":"Dan"},{"given":"Hannah","family":"Stocker","display":"Stocker, Hannah","role":"aut"},{"given":"Tobias","family":"Möllers","display":"Möllers, Tobias","role":"aut"},{"role":"aut","given":"Konrad","display":"Beyreuther, Konrad","family":"Beyreuther"},{"given":"Hermann","display":"Brenner, Hermann","family":"Brenner","role":"aut"},{"given":"Ben","family":"Schöttker","display":"Schöttker, Ben","role":"aut"}],"physDesc":[{"extent":"10 S."}],"title":[{"title":"Associations of urinary 8-iso-prostaglandin F2α levels with all-cause dementia, Alzheimer's disease, and vascular dementia incidence","subtitle":"results from a prospective cohort study","title_sort":"Associations of urinary 8-iso-prostaglandin F2α levels with all-cause dementia, Alzheimer's disease, and vascular dementia incidence"}],"titleAlt":[{"title":"Associations of urinary 8-iso-prostaglandin F2 alpha levels with all-cause dementia, Alzheimer's disease, and vascular dementia incidence$dresults from a prospective cohort study"}],"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"12 April 2020"}],"name":{"displayForm":["Kira Trares, Xīn Gào, Laura Perna, Dan Rujescu, Hannah Stocker, Tobias Möllers, Konrad Beyreuther, Hermann Brenner, Ben Schöttker"]},"recId":"1738318966","note":["Im Titel ist \"2α\" tiefgestellt","Gesehen am 10.11.2020"]} 
SRT |a TRARESKIRAASSOCIATIO1220